Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 stadistical analysis between TLRs expressions and clinicopathological factors in women with breast carcinomas.

From: Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis

Characteristics TLR3 TLR4 TLR9
  median (range) p median (range) p median (range) p
Menopausal Status       
Premenopausal 51.4 (0-158) 0.048 57.37 (0-160) 0.006 138.7 (46-268) 0.319
Postmenopausal 65.9 (0-166)   72.33 (0-158)   153 (37-272)  
Tumoral size       
T1 49.7 (0-166) 0.005 62.7 (0-160) 0.039 140.2 (37-272) 0.269
T2 69.2 (0-162)   71.2 (38-158)   151.4 (46-268)  
Nodal status       
N- 60.5 (0-162) 0.717 68 (0-143) 0.725 147.5 (38-246) 0.724
N+ 60.5 (0-166)   68.7 (36-160)   153 (46-272)  
Estrogen receptors       
Negative 63.7 (0-166) 0.923 67.1 (0-159) 0.436 150.5 (46-272) 0.904
Positive 59.9 (0-162)   69.4 (0-156.2)   148 (37-268)  
Progesterone receptors       
Negative 67.3 (0-166) 0.101 70 (0-158) 0.396 150.3 (46-272) 0.251
Positive 57.1 (0-158)   62.8 (38-135)   137.4 (37-268)  
Tumoral progess       
Expansive 62.7 (0-162) 0.863 71.6 (0-160) 0.247 151.8 (65-272) 0.167
Infiltrating 59.9 (0-166)   62.1 (0-156)   143.1 (38-268)  
Stage       
I 46 (0-70) 0.024 62.8 (0-135) 0.175 136.9 (37-180) 0.035
II 62.4 (0-162)   69.3 (38-160)   155.9 (46-268)  
III 72.3 (0-166)   69 (36-158)   147.5 (60-272)  
SBR       
SBRI 57.1 (0-102) 0.671 62.8 (0-135) 0.201 137.9 (38-272) 0.218
SBRII 57.9 (0-166)   66.5 (0-160)   148.4 (60-246)  
SBRIII 64.3 (0-158)   96.2 (0-158)   161.7 (46-268)  
Peritumoral inflamation       
No 57.9 (0.162) 0.815 67.5 (0-156) 0.815 141.7 (37-272) 0.191
Mild 61 (0-166)   69.4 (0-160)   158,2 (46-268)  
Intense 60 (50-70)   88.4 (62-114)   137.7 (115-159)  
Tumoral necrosis       
No 57.5 (0-166) 0.359 68 (0-158) 0.184 147.5 (38-272) 0.095
Focal 69.7 (0-162)   64.4 (46-125)   151.1 (119-173)  
Extense 71.4 (29-113)   133.2 (106-160)   214.6 (183-246)